Viewing Study NCT01349933


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-01-09 @ 8:32 AM
Study NCT ID: NCT01349933
Status: COMPLETED
Last Update Posted: 2017-12-05
First Post: 2011-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Squamous Cell Carcinoma of the Nasopharynx View
None Stage IV Squamous Cell Carcinoma of the Nasopharynx View
Keywords: